The validation of a simulation model incorporating radiation risk for mammography breast cancer screening in women with a hereditary-increased breast cancer risk

European Journal of Cancer

Volumn 46, Issue 3, 2010, Pages 495-504

  Greuter, Marcel J W ^a   Jansen van der Weide, Marijke C ^a   Jacobi, Cathrien E ^b   Oosterwijk, Jan C ^a   Jansen, Liesbeth ^a   Oudkerk, Matthijs ^a   de Bock, Geertruida H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BRCA1 and BRCA2 genes; Breast cancer; Hereditary cancer; Radiation induced neoplasm; Risk assessment; Screening

Indexed keywords

ACCURACY; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; CONTROLLED STUDY; FAMILIAL CANCER; MAMMOGRAPHY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RADIATION HAZARD; SENSITIVITY ANALYSIS; SIMULATION; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASMS, RADIATION-INDUCED; RADIATION DOSAGE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 75149113120     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.10.030     Document Type: Article

References (59)

1. Botha J.L., Bray F., Sankila R., and Parkin D.M. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 39 (2003) 1818-1829
2. Chen S., and Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25 (2007) 1329-1333
3. Jatoi I., Zhu K., Shah M., and Lawrence W. Psychological distress in US women who have experienced false-positive mammograms. Breast Cancer Res Treat 100 (2006) 191-200
4. Keen J.D., and Keen J.E. What is the point: will screening mammography save my life?. BMC Med Inform Decis Mak 9 (2009) 18
5. Maurice A., Evans D.G., Shenton A., Ashcroft L., Baildam A., Barr L., et al. Screening younger women with a family history of breast cancer-does early detection improve outcome?. Eur J Cancer 42 (2006) 1385-1390
6. Weedon-Fekjaer H., Lindqvist B.H., Vatten L.J., Aalen O.O., and Tretli S. Breast cancer tumor growth estimated through mammography screening data. Breast Cancer Res 10 (2008) R41
7. BEIR 7. National Research Council, Committee on the Biological Effects of Ionizing Radiation. Health effects of exposure to low levels of ionizing radiation (BEIR VII Phase 2). Washington DC: National Academy Press; 2006.
8. Preston D.L., Mattsson A., Holmberg E., Shore R., Hildreth N.G., and Boice Jr. J.D. Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res 158 (2002) 220-235
9. Thompson D.E., Mabuchi K., Ron E., Soda M., Tokunaga M., Ochikubo S., et al. Cancer incidence in atomic bomb survivors. Part II: colid tumours, 1958-1987. Radiat Res 137 (1994) S17-S67
10. Shapiro S., Coleman E.A., Broeders M., Codd M., de Koning H., Fracheboud J., et al. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int J Epidemiol 27 (1998) 735-742
11. Gronwald J., Pijpe A., Byrski T., Huzarski T., Stawicka M., Cybulski C., et al. Early radiation exposures and BRCA1-associated breast cancer in young women from Poland. Breast Cancer Res Treat 112 (2008) 581-584
12. Broeks A., Braaf L.M., Huseinovic A., Nooijen A., Urbanus J., Hogervorst F.B., et al. Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study. Breast Cancer Res 9 (2007) R26
13. Jacobi C.E., Nagelkerke N.J., van Houwelingen J.H., and de Bock G.H. Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study. Cancer Epidemiol Biomarkers Prev 15 (2006) 429-436
14. Peer P.G., van Dijck J.A., Hendriks J.H., Holland R., and Verbeek A.L. Age-dependent growth rate of primary breast cancer. Cancer 71 (1993) 3547-3551
15. Van der Helm O.M., Bouwman R.W., Geertse T.D., et al. Results of Technical Quality Control in the Dutch Screening Programma (2003-2004) (2006), National Expert and Training Center for Breast Cancer Screening, Nijmegen, The Netherlands
16. Peer P.G., Verbeek A.L., Straatman H., Hendriks J.H., and Holland R. Age-specific sensitivities of mammographic screening for breast cancer. Breast Cancer Res Treat 38 (1996) 153-160
17. Easton D.F., Ford D., and Bishop D.T. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56 (1995) 265-271
18. Ford D., Easton D.F., Stratton M., Narod S., Goldgar D., Devilee P., et al. Breast Cancer Linkage Consortium. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62 (1998) 676-689
19. Jonker M.A., Jacobi C.E., Hoogendoorn W.E., Nagelkerke N.J., de Bock G.H., and van Houwelingen J.C. Modeling familial clustered breast cancer using published data. Cancer Epidemiol Biomarkers Prev 12 (2003) 1479-1485
20. Cortesi L., Turchetti D., Marchi I., Fracca A., Canossi B., Rachele B., et al. Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience. BMC Cancer 6 (2006) 210
21. Kriege M., Brekelmans C.T., Boetes C., Muller S.H., Zonderland H.M., Obdeijn I.M., et al. Dutch MRI Screening (MRISC) Study Group. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition. Cancer 106 (2006) 2318-2326
22. Leach M.O., Boggis C.R., Dixon A.K., Easton D.F., Eeles R.A., Evans D.G., et al. MARIBS study group. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365 (2005) 1769-1778
23. Warner E., Plewes D.B., Hill K.A., Causer P.A., Zubovits J.T., Jong R.A., et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292 (2004) 1317-1325
24. Sim L.S., Hendriks J.H., and Fook-Chong S.M. Breast ultrasound in women with familial risk of breast cancer. Ann Acad Med Singapore 33 (2004) 600-606
25. Halapy E., Chiarelli A.M., Klar N., and Knight J.A. Accuracy of breast screening among women with and without a family history of breast and/or ovarian cancer. Breast Cancer Res Treat 90 (2005) 299-305
26. Trecate G., Vergnaghi D., Manoukian S., Bergonzi S., Scaperrotta G., Marchesini M., et al. MRI in the early detection of breast cancer in women with high genetic risk. Tumori 92 (2006) 517-523
27. Gui G.P., Kadayaprath G., Darhouse N., Self J., Ward A., A'Hern R., et al. Clinical outcome and service implications of screening women at increased breast cancer risk from a family history. Eur J Surg Oncol 32 (2006) 719-724
28. Murday V., Pears R., Ball J., Eeles R., and Hodgson S. An audit of screening for familial breast cancer before 50 years in the South Thames Region - have we got it right?. Fam Cancer 3 (2004) 29-34
29. Kuhl C.K., Schrading S., Leutner C.C., Morakkabati-Spitz N., Wardelmann E., Fimmers R., et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23 (2005) 8469-8476
30. Schmutzler R.K., Rhiem K., Breuer P., Wardelmann E., Lehnert M., Coburger S., et al. Outcome of a structured surveillance programme in women with a familial predisposition for breast cancer. Eur J Cancer Prev 15 (2006) 483-489
31. Tilanus-Linthorst M.M., Obdeijn I.M., Hop W.C., Causer P.A., Leach M.O., Warner E., et al. BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials. Clin Cancer Res 13 (2007) 7357-7362
32. Warner E., Messersmith H., Causer P., Eisen A., Shumak R., and Plewes D. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148 (2008) 671-679
33. Weedon-Fekjær H., Lindqvist B.H., Vatten L.J., Aalen O.O., and Tretli S. Breast cancer tumor growth estimated through mammography screening data. Breast Cancer Res 10 (2008) R41
34. Young K.C., Burch A., and Oduko J.M. Radiation doses received in the UK Breast Screening Programme in 2001 and 2002. Brit J Radiol 78 (2005) 207-218
35. Kruger R.L., and Schueler B.A. A survey of clinical factors and patient dose in mammography. Med Phys 28 (2001) 1449-1454
36. Rosenquist C.J., and Lindfors K.K. Screening mammography in women aged 40-49 years: analysis of cost-effectiveness. Radiology 191 (1994) 647-650
37. Michaelson J.S., Halpern E., and Kopans D.B. Breast cancer: computer simulation method for estimating optimal intervals for screening. Radiology 212 (1999) 551-560
38. Fett M.J. Computer modelling of the Swedish two county trial of mammographic screening and trade offs between participation and screening interval. J Med Screen 8 (2001) 39-45
39. Szeto K.L., and Devlin N.J. The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand. Health Policy 38 (1996) 101-115
40. Cronin K.A., Mariotto A.B., Clarke L.D., and Feuer E.J. Additional common inputs for analyzing impact of adjuvant therapy and mammography on US mortality. J Natl Cancer Inst Monogr 36 (2006) 26-29
41. Berry D.A., Inoue L., Shen Y., Venier J., Cohen D., Bondy M., et al. Modeling the impact of treatment and screening on US breast cancer mortality: a Bayesian approach. J Natl Cancer Inst Monogr 36 (2006) 30-36
42. Fryback D.G., Stout N.K., Rosenberg M.A., Trentham-Dietz A., Kuruchittham V., and Remington P.L. The Wisconsin breast cancer epidemiology simulation model. J Natl Cancer Inst Monogr 36 (2006) 37-47
43. Mandelblatt J., Schechter C.B., Lawrence W., Yi B., and Cullen J. The SPECTRUM population model of the impact of screening and treatment on US breast cancer trends from 1975 to 2000: principles and practice of the model methods. J Natl Cancer Inst Monogr 36 (2006) 47-55
44. Tan S.Y.G.L., Van Oortmarssen G.J., De Koning H.J., Boer R., and Habbema J.D.F. The MISCAN-Fadia continuous tumor growth model for breast cancer. J Natl Cancer Inst Monogr 36 (2006) 56-65
45. Hanin L.G., Miller A., Zorin A.V., and Yakovlev A.Y. The University of Rochester model of breast cancer detection and survival. J Natl Cancer Inst Monogr 36 (2006) 66-78
46. Lee S., and Zelen M. A stochastic model for predicting the mortality of breast cancer. J Natl Cancer Inst Monogr 36 (2006) 79-86
47. Plevritis S.K., Sigal B.M., Salzman P., Rosenberg J., and Glynn P. A stochastic simulation model of US breast cancer mortality trends from 1975 to 2000. J Natl Cancer Inst Monogr 36 (2006) 86-95
48. Clarke L.D., Plevritis S.K., Boer R., Cronin K.A., and Feuer E.J. A comparative review of CISNET breast models used to analyze US breast cancer incidence and mortality trends. J Natl Cancer Inst Monogr 36 (2006) 96-105
49. Habbema J.D.F., Tan S.Y.G.L., and Cronin K.A. Impact of mammography on US breast cancer mortality, 1975-2000: are intermediate outcome measures informative?. J Natl Cancer Inst Monogr 36 (2006) 105-111
50. Cronin K.A., Feuer E.J., Clarke L.D., and Plevritis S.K. Impact of adjuvant therapy and mammography on US mortality from 1975 to 2000: comparison of mortality results from the CISNET breast cancer base case analysis. J Natl Cancer Inst Monogr 36 (2006) 112-121
51. Habbema J.D.F., Schechter C.B., Cronin K.A., Clarke L.D., and Feuer E.J. Modeling cancer natural history, epidemiology, and control: reflections on the CISNET breast group experience. J Natl Cancer Inst Monogr 36 (2006) 122-126
52. Jansen J.T., and Zoetelief J. Optimisation of mammographic breast cancer screening using a computer simulation model. Eur J Radiol 24 (1997) 137-144
53. Beemsterboer P.M., Warmerdam P.G., Boer R., and de Koning H.J. Radiation risk of mammography related to benefit in screening programmes: a favourable balance?. J Med Screen 5 (1998) 81-87
54. BEIR 5. National Research Council, Committee on the Biological Effects of Ionizing Radiation. Health effects of exposure to low levels of ionizing radiation. Washington DC: National Academy Press; 1990.
55. Plevritis S.K., Kurian A.W., Sigal B.M., Daniel B.L., Ikeda D.M., Stockdale F.E., et al. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA 295 (2006) 2374-2384
56. Box G.E.P., and Müller M.E. A note on the generation of random normal deviates. Ann Math Stat 29 (1958) 610-611
57. ICRP (International Commission of Radiological Protection). ICRP Publication 60: 1990 Recommendations of the ICRP. Oxford, UK: Pergamon, Elsevier Science; 1990.
58. EPA (Environmental Protection Agency). Estimating radiogenic cancer risks. Addendum: uncertainty analysis. Washington DC: US Environmental Protection Agency; 1999.
59. UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation). 2000. Sources and effects of ionizing radiation. UNSCEAR Report to the general assembly, vol. II: Effects. New York: United Nations.